Fig. 2From: Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial(a) Distribution of NYHA functional class among patients implanted with aortic bioprosthesis at pre-procedure, and post-procedure till 12-month; (b) Distribution of NYHA functional class among patients implanted with mitral bioprosthesis at pre-procedure, and post-procedure till 12-monthBack to article page